Post Operative Pain Management Market Report 2026

The post operative pain management market size has grown strongly in recent years. It will grow from $39.27 billion in 2025 to $41.66 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to increasing number of surgical procedures, widespread use of opioid-based analgesics, expansion of hospital-based pain management programs, availability of injectable pain therapies, growing awareness of postoperative care standards.

The post operative pain management market size is expected to see strong growth in the next few years. It will grow to $52.27 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to increasing demand for opioid-sparing pain management, rising adoption of digital pain monitoring tools, expansion of enhanced recovery after surgery protocols, growing focus on patient-centric pain care, increasing investment in advanced analgesic therapies. Major trends in the forecast period include increasing adoption of multimodal pain management approaches, growing use of patient-controlled analgesia systems, rising focus on non-opioid pain therapies, expansion of personalized post-surgical pain protocols, enhanced monitoring of postoperative recovery.

The increasing volume of surgical procedures is expected to drive the growth of the postoperative pain management market going forward. Surgical procedures are medical operations performed by qualified surgeons to diagnose, treat, or manage diseases, injuries, or medical conditions. The rise in surgical procedures is supported by factors such as an aging population, a higher prevalence of chronic diseases, advancements in medical technology, improved access to healthcare services, and growing demand for elective surgeries. Effective postoperative pain management supports recovery by reducing complications, improving patient comfort, and enabling better surgical outcomes through appropriate pain control and faster rehabilitation. For instance, in December 2023, according to the UK Health Security Agency, a UK-based government agency, the number of coronary artery bypass graft surgeries increased in 2023, reaching 27,524 procedures compared to previous years. Therefore, the growing number of surgical procedures is driving the growth of the postoperative pain management market.

Major companies operating in the postoperative pain management market are focusing on developing technological innovations such as cryoablation probes to effectively reduce pain by targeting nerves through controlled cooling. A cryoablation probe is a medical device designed to freeze and deactivate targeted nerve tissue or abnormal cells, commonly used in pain management and tumor treatment. For instance, in October 2024, AtriCure Inc., a US-based medical device company, launched the cryoSPHERE MAX probe. This device enhances postoperative pain management by temporarily interrupting pain signals through precise freezing of peripheral nerves. Its advanced design shortens freeze times and improves tissue contact, resulting in more efficient and effective pain relief. The next-generation probe incorporates improvements in insulation, nitrous oxide gas utilization, tactile tissue feedback, and real-time temperature monitoring.

In January 2024, Heron Therapeutics Inc., a US-based biotechnology company, partnered with Cross Link Life Sciences LLC to expand its sales network and improve access to Zynrelef for postoperative pain management in orthopedic surgery patients. This partnership aims to broaden the availability of advanced pain management solutions by leveraging Cross Link Life Sciences’ expertise in surgical and pain management applications. Cross Link Life Sciences LLC is a US-based medical device company specializing in innovative solutions for surgical care and pain management.

Major companies operating in the post operative pain management market are Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sun Pharmaceutical Industries Ltd., Cipla Inc., Hikma Pharmaceuticals PLC, Mallinckrodt plc, Pacira BioSciences Inc, Endo International plc, Heron Therapeutics Inc., Cara Therapeutics Inc., Scilex Pharmaceuticals Inc., Taiwan Liposome Company Ltd, Durect Corporation, Trevena Inc., Teikoku Pharma USA Inc, AFT Pharmaceuticals Limited, Allay Therapeutics Inc, Virpax Pharmaceuticals Inc.

North America was the largest region in the postoperative pain management market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post operative pain management market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the post operative pain management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the postoperative pain management market by increasing costs of imported pharmaceutical ingredients, medical infusion devices, monitoring equipment, and drug delivery systems. Hospitals and surgical centers in North America and Europe are most affected due to reliance on imported drugs and devices, while Asia-Pacific faces higher production and distribution costs. These tariffs are contributing to increased treatment expenses and procurement challenges. However, they are also supporting local pharmaceutical manufacturing, regional supply chain diversification, and development of cost-efficient pain management solutions.

The post operative pain management market research report is one of a series of new reports that provides post operative pain management market statistics, including post operative pain management industry global market size, regional shares, competitors with a post operative pain management market share, detailed post operative pain management market segments, market trends and opportunities, and any further data you may need to thrive in the post operative pain management industry. This post operative pain management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Postoperative pain management refers to the methods and therapies used to control and alleviate pain following surgical procedures. It includes both pharmacological and non-pharmacological approaches aimed at improving patient comfort, supporting recovery, minimizing complications, and enhancing overall surgical outcomes.

The primary pain types addressed in post-operative pain management include acute pain, moderate pain, and severe pain. Acute pain is a sudden and intense discomfort that typically lasts for a short period and is commonly associated with surgery, injury, or illness. Pain management involves the use of various drug classes, such as opioids, non-steroidal anti-inflammatory drugs (NSAIDs), cyclooxygenase-2-selective inhibitors (COX-2 inhibitors), and other medications. These treatments are administered through multiple routes, including injectable, oral, and topical, and are distributed via hospital and retail pharmacies. Applications of pain management include cancer pain, arthritic pain, neuropathic pain, musculoskeletal pain, and migraines.

The postoperative pain management market consists of revenues earned by entities by providing services such as pharmacological treatments, treatment services, physical therapy and rehabilitation, and psychological support and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The postoperative pain management market also includes sales of pharmaceuticals, patient-controlled analgesia (PCA) pumps, cryotherapy, and heat therapy devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.